Amphastar Pharmaceuticals Inc 2025年季度报告

FORM10-Q ⌧QUARTERLY REPORTPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 FOR THEQUARTERLY PERIODENDED JUNE 30,2025or ◻TRANSITION REPORTPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period fromtoCommission file number001-36509 AMPHASTAR PHARMACEUTICALS, INC. (Exact name of Registrant as specified in its charter) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section13or15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required tofile such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes⌧No◻ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter periodthat the registrant was required to submit such files).Yes⌧No◻ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Largeacceleratedfiler⌧Non-acceleratedfiler◻ If anemerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodfor complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.◻ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the ExchangeAct).Yes◻No⌧ Securities registered pursuant to Section 12(b) of the Act: The number of shares outstanding of the registrant’s only class of common stock as of August 1, 2025 was46,495,077. AMPHASTAR PHARMACEUTICALS, INC.TABLE OF CONTENTSFORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 Special Note About Forward-Looking Statements Part I. FINANCIAL INFORMATION PAGE Item1. Financial Statements (unaudited):Condensed Consolidated Balance Sheets as of June 30, 2025 and December31, 20241Condensed Consolidated Statements of Operations for the Three and SixMonths Ended June 30, 2025 and 20242Condensed Consolidated Statements of Comprehensive Income for the Threeand Six Months Ended June 30, 2025 and 20243Condensed Consolidated Statements of Stockholders’ Equity for the Threeand Six Months Ended June 30, 2025 and 20244Condensed Consolidated Statements of Cash Flows for the Six Months EndedJune 30, 2025 and 20245Notes to Condensed Consolidated Financial Statements6Item 2. Management’s Discussion and Analysis of Financial Condition and Results ofOperations28Item 3. Quantitative and Qualitative Disclosure about Market Risk38Item 4. Controls and Procedures38Part II. OTHER INFORMATIONItem 1. Legal Proceedings39Item 1A. Risk Factors39Item 2. Unregistered Sales of Equity Securities and Use of Proceeds43Item 3. Defaults Upon Senior Securities43Item 4. Mine Safety Disclosures43Item 5. Other Information43Item 6. Exhibits44Signatures45 SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, or Quarterly Report, contains “forward-looking statements” that involvesubstantial risks and uncertainties. In some cases, you can identify forward-looking statements by the followingwords: “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,”“estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or othercomparable terminology, although not all forward-looking statements contain these identifying words. Forward-looking statements relate to future events or future financial performance or condition and involve known andunknown risks, uncertainties and other factors that could cause actual results, levels of activity, performance orachievement to differ materially from those expressed or implied by the forward-looking statements. Theseforward-looking statements include, but are not limited to, statements about: ●our expectations regarding the sales and marketing of our products;●our expectations regarding our manufacturing and production and the integrity of our supply chain forour products, including the risks associated with our single source suppliers;●our business and operations in general, including: adverse impacts of global conflicts and challengingmacroeconomic conditions and market uncertainty on our business, financial condition, operations, cashflows and liquidity;●our ability to attract, hire, and retain highly skilled personnel;●interruptions to our manufacturing and production as a result of natural catastrophic events or othercauses beyond our control such as power disruptions, pandemics, wars, terrorist attacks or other events;